PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
+12.43%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$137M
AUM Growth
+$137M
(-22%)
Cap. Flow
-$94.1M
Cap. Flow
% of AUM
-68.42%
Top 10 Holdings %
Top 10 Hldgs %
99.81%
Holding
11
New
–
Increased
–
Reduced
3
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Cardlytics
CDLX
|
$82.2M |
| 2 |
KALA BIO
KALA
|
$2.33M |
Sector Composition
| 1 | Healthcare | 28.58% |
| 2 | Communication Services | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Fate Therapeutics
FATE
$120M
| $22.3M | 16.22% | 1,139,783 | – | – |
|
|
2
Cardlytics
CDLX
$54.3M
| $12.6M | 9.14% | 200,000 -1,308,065 | -87% | -$82.2M |
|
3
Cartesian Therapeutics
RNAC
$261M
| $6.65M | 4.84% | 2,773,479 | – | – |
|
4
X4 Pharmaceuticals
XFOR
$84.2M
| $3.33M | 2.42% | 311,492 | – | – |
|
5
Neuronetics
STIM
$220M
| $3.29M | 2.39% | 732,583 | – | – |
|
|
6
KALA BIO
KALA
$78.8M
| $2.09M | 1.52% | 565,289 -631,743 | -53% | -$2.33M |
|
|
ATYR
7
aTyr Pharma
ATYR
$527M
| $544K | 0.4% | 130,571 | – | – |
|
|
GNCA
8
DELISTED
Genocea Biosciences, Inc.
GNCA
| $509K | 0.37% | 246,078 | – | – |
|
9
Pulmatrix
PULM
$18M
| $309K | 0.22% | 359,439 | – | – |
|
10
Dare Bioscience
DARE
$27.2M
| $268K | 0.19% | 326,243 | – | – |
|